Red Cell Partners is a venture capital firm focused on incubating and investing in technology-led companies addressing critical challenges in healthcare and national security. The firm targets rapidly-scalable solutions that bring revolutionary advancements to market. Red Cell Partners typically invests across various stages, from pre-seed to later rounds, with investments ranging from $3 million to $200 million.
Notable portfolio companies include Epirus, a directed energy systems company, and Paravision, an AI-powered computer vision platform. Red Cell Partners offers value-add services through its incubation model, leveraging deep industry expertise to develop powerful tools and solutions. The firm's leadership includes partners with backgrounds in technology, healthcare, and national security, positioning them to provide strategic guidance to portfolio companies in these sectors.
Portfolio Snapshot
Observed round participation, including acquisitions and grants. Current holdings, investor exits, and write-offs are not established.
